[Article 3.2] of the Agreement is hereby deleted and replaced with the following:

Article Headings. Article headings and article and section numbers are inserted herein only as a matter of convenience and in no way define, limit, or prescribe the scope or intent of this Agreement or any part hereof and shall not be considered in interpreting or construing this Agreement.

[Article 1.1] of the License shall be superseded and replaced with the following:

) ARTICLE B.3. OPTIONS, is modified to incorporate CLIN 0009 for the Emergency Distribution of Procured Antibiotic from VMI and funding in the amount of $43,483.00.

) ARTICLE B.4 ADVANCE UNDERSTANDINGS is modified to include additional language under paragraph m, VMI.

) ARTICLE C.1. STATEMENT OF WORK, and SECTION J, LIST OF ATTACHMENTS is modified to incorporate revised Statement of Work, dated July 22, 2021, in its entirety.

[Article 1.33] is hereby deleted in its entirety and replaced as follows:

[Article V]. [Section 5.1] – Wherever “NAI” appears in [Section 5.1], “[[Organization A:Organization]]” shall be substituted and a new sentence at the end of the Section is hereby added to read as follows:

In [Article 2.3], second line, insert after “…except that during and for the Term only…”: “(or thereafter, if the Commercial License has become perpetual, irrevocable, fully paid up and royalty free as provided for in [Article 3.1.3] in all countries),”.

Building:That certain life sciences building containing approximately 19,957 rentable square feet of space located at 11585 Sorrento Valley Road, San Diego, California 92121 (the “Building”).